In this article
Rectal cancer is cancer that occurs in the last few inches of the colon, an area called the rectum. If detected early, the long-term survival rate is about 85% to 90%, but if the cancer spreads to the lymph nodes, survival rates drop sharply. Most rectal cancers start with small non-cancerous growths called polyps, which can be removed before they become cancerous β making timely colonoscopy screening critically important. Prevention guidelines generally recommend colonoscopy screening beginning at age 50, or earlier for those with risk factors such as a family history of colorectal cancer.
Many patients with rectal cancer have no signs or symptoms in the early stages. Later-stage symptoms may include rectal bleeding (often bright red and frequently mistaken for hemorrhoids), changes in bowel habits, abdominal discomfort, rectal pain, and a persistent feeling of needing to use the bathroom. Patients should not assume rectal bleeding is due to hemorrhoids without a proper medical examination to rule out polyps or cancer. Diagnosis is confirmed through a combination of colonoscopy, CT scan or X-ray, and additional tests such as endoscopic ultrasonography or MRI to determine whether the cancer has penetrated beyond the rectum or involved nearby lymph nodes.
Rectal cancer is staged based on how far the tumor has progressed. Stage I cancer has not grown through the rectal wall and has not spread to lymph nodes. Stage II involves a tumor that has invaded or slightly passed through the rectal wall without lymph node involvement. Stage III means the cancer has spread to nearby lymph nodes, and Stage IV indicates the cancer has spread to other areas of the body.
Surgery is the most common treatment across all stages and involves removing the cancerous portion of the rectum along with margins of healthy tissue and nearby lymph nodes. When possible, the surgeon reconnects the remaining healthy portions of the rectum and colon. If reconnection is not possible, a permanent colostomy β an opening through the abdominal wall β may be required. For locally advanced rectal cancer at Stage II or III, chemotherapy and radiation therapy are typically used before surgery to shrink the tumor and improve the likelihood of complete removal, followed by additional chemotherapy after surgery. Patients are strongly advised to consult their doctor promptly when early symptoms appear, particularly rectal bleeding, changes in stool size or characteristics, or persistent rectal discomfort.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination β travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

About Dr. Nishant Mittal
Dr. Nishant Mittal is a highly accomplished researcher with over 13 years of experience in the fields of cardiovascular biology and cancer research. Significant contributions to stem cell biology, developmental biology, and innovative research techniques mark his career. Research Highlights Dr. Mittal's research has focused on several key areas: 1) Cardioβ¦
β Reviewed for medical accuracy by the CancerFax review panel.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.
